MARKET

OCGN

OCGN

Ocugen Inc
NASDAQ
1.220
-0.020
-1.61%
After Hours: 1.221 +0.001 +0.04% 19:52 12/05 EST
OPEN
1.240
PREV CLOSE
1.240
HIGH
1.260
LOW
1.220
VOLUME
2.36M
TURNOVER
--
52 WEEK HIGH
1.900
52 WEEK LOW
0.5150
MARKET CAP
381.03M
P/E (TTM)
-5.6273
1D
5D
1M
3M
1Y
5Y
1D
Ocugen Inc. Stock Slips 4.8%, Underperforms Market
Dow Jones · 5d ago
Weekly Report: what happened at OCGN last week (1124-1128)?
Weekly Report · 5d ago
Ocugen Inc. Stock Advances 5.1%, Outperforms Market
Dow Jones · 11/28 21:33
SA Quant ranks Goldman's small-cap stocks with largest short interest
Seeking Alpha · 11/26 20:13
Weekly Report: what happened at OCGN last week (1117-1121)?
Weekly Report · 11/24 09:40
Ocugen CEO to Present at NobleCon21 Emerging Growth Equity Conference
Reuters · 11/20 12:02
Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference
Barchart · 11/20 06:02
Weekly Report: what happened at OCGN last week (1110-1114)?
Weekly Report · 11/17 09:40
More
About OCGN
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. Its technology pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. It is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. It is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.

Webull offers Ocugen Inc stock information, including NASDAQ: OCGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCGN stock methods without spending real money on the virtual paper trading platform.